loading
Tectonic Therapeutic Inc stock is traded at $15.77, with a volume of 23,830. It is down -1.94% in the last 24 hours and down -11.34% over the past month. Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
See More
Previous Close:
$16.02
Open:
$16.02
24h Volume:
23,830
Relative Volume:
0.06
Market Cap:
$295.00M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.36%
1M Performance:
-11.34%
6M Performance:
-2.78%
1Y Performance:
-49.90%
1-Day Range:
Value
$15.70
$16.67
1-Week Range:
Value
$14.60
$18.03
52-Week Range:
Value
$13.70
$61.07

Tectonic Therapeutic Inc Stock (TECX) Company Profile

Name
Name
Tectonic Therapeutic Inc
Name
Phone
(339) 666-3320
Name
Address
490 ARSENAL WAY, WATERTOWN
Name
Employee
51
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
TECX's Discussions on Twitter

Compare TECX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TECX
Tectonic Therapeutic Inc
15.77 299.77M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
405.64 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.22 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
542.01 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
795.45 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
326.40 35.16B 4.56B -176.77M 225.30M -1.7177

Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-03-25 Initiated Oppenheimer Outperform
Jul-21-25 Initiated Truist Buy
Jun-11-25 Resumed Raymond James Outperform
Apr-21-25 Initiated Mizuho Outperform
Nov-20-24 Initiated Raymond James Outperform
Aug-22-24 Initiated Wells Fargo Overweight
Jun-26-24 Initiated Piper Sandler Overweight
Jun-24-24 Initiated TD Cowen Buy
Dec-18-23 Downgrade Mizuho Buy → Neutral
Jan-05-22 Downgrade BTIG Research Buy → Neutral
Nov-19-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-15-21 Initiated BTIG Research Buy
May-27-21 Initiated Needham Buy
Mar-09-21 Initiated Barclays Overweight
Mar-02-21 Initiated Stifel Hold
Nov-11-20 Initiated Berenberg Buy
Mar-31-20 Downgrade H.C. Wainwright Buy → Neutral
Jun-27-19 Initiated Mizuho Buy
Apr-05-19 Initiated Janney Buy
Oct-10-18 Initiated Guggenheim Buy
Oct-02-18 Reiterated H.C. Wainwright Buy
Sep-17-18 Initiated H.C. Wainwright Buy
Jul-16-18 Initiated Wedbush Outperform
Jul-16-18 Initiated Wells Fargo Outperform
View All

Tectonic Therapeutic Inc Stock (TECX) Latest News

pulisher
02:20 AM

Is it time to cut losses on Tectonic Therapeutic Inc.July 2025 Momentum & Entry and Exit Point Strategies - newser.com

02:20 AM
pulisher
Oct 12, 2025

Bullish Tectonic Therapeutic Insiders Loaded Up On US$61.2m Of Stock - Yahoo

Oct 12, 2025
pulisher
Oct 12, 2025

Will Tectonic Therapeutic Inc. benefit from macro trendsEarnings Summary Report & Reliable Intraday Trade Alerts - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Oct 11, 2025
pulisher
Oct 10, 2025

Has Tectonic Therapeutic Inc. found a price floorWeekly Trade Report & Technical Confirmation Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

News impact scoring models applied to Tectonic Therapeutic Inc.July 2025 Levels & Verified Chart Pattern Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Key resistance and support levels for Tectonic Therapeutic Inc.July 2025 News Drivers & Weekly High Return Stock Forecasts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Tectonic Therapeutic (NASDAQ:TECX) Trading Up 3%Here's Why - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Tectonic Therapeutic (NASDAQ:TECX) Shares Up 3%Here's What Happened - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Tectonic Therapeutic’s (TECX) “Sell (D-)” Rating Reaffirmed at Weiss Ratings - Defense World

Oct 09, 2025
pulisher
Oct 09, 2025

Tectonic Therapeutic's (TECX) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 06, 2025

Chart based exit strategy for Tectonic Therapeutic Inc.July 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Tectonic Therapeutic Inc. continue its uptrendInsider Buying & Technical Entry and Exit Tips - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Is Tectonic Therapeutic Inc. stock entering bullish territoryTrade Entry Report & Safe Entry Trade Signal Reports - newser.com

Oct 05, 2025
pulisher
Sep 29, 2025

Tectonic Therapeutic stock soars on positive trial data - MSN

Sep 29, 2025
pulisher
Sep 28, 2025

Is Tectonic Therapeutic Inc a good long term investmentRisk Management Strategies & Build Winning Strategies With Zero Cost - Early Times

Sep 28, 2025
pulisher
Sep 27, 2025

What MACD and RSI say about Tectonic Therapeutic Inc.July 2025 Institutional & Momentum Based Trading Ideas - newser.com

Sep 27, 2025
pulisher
Sep 26, 2025

What drives Tectonic Therapeutic Inc stock pricePrice Support Zones & Turn Bull Runs into Life-Changing Wealth - Early Times

Sep 26, 2025
pulisher
Sep 26, 2025

Analyzing drawdowns of Tectonic Therapeutic Inc. with statistical toolsMarket Rally & Free Risk Controlled Daily Trade Plans - newser.com

Sep 26, 2025
pulisher
Sep 25, 2025

Is Tectonic Therapeutic Inc. still worth holding after the dipEarnings Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com

Sep 25, 2025
pulisher
Sep 24, 2025

Is a relief rally coming for Tectonic Therapeutic Inc. holders2025 Price Momentum & Weekly Setup with ROI Potential - newser.com

Sep 24, 2025
pulisher
Sep 22, 2025

Sector ETF performance correlation with Tectonic Therapeutic Inc.Exit Point & Smart Investment Allocation Insights - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

Is Tectonic Therapeutic Inc. stock ready for a breakoutJuly 2025 Spike Watch & Weekly Top Performers Watchlists - newser.com

Sep 21, 2025
pulisher
Sep 21, 2025

Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

CEO Moves: What are Tectonic Therapeutic Incs earnings expectationsJuly 2025 Review & Risk Managed Trade Strategies - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Will Tectonic Therapeutic Inc. stock recover after recent dropJuly 2025 Fed Impact & Real-Time Market Trend Scan - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Targets Report: Will Tectonic Therapeutic Inc benefit from rate cutsJuly 2025 Retail & Fast Gain Stock Trading Tips - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Rate Cut: Is Tectonic Therapeutic Inc stock technically oversold2025 Historical Comparison & Weekly Watchlist of Top Performers - خودرو بانک

Sep 20, 2025

Tectonic Therapeutic Inc Stock (TECX) Financials Data

There is no financial data for Tectonic Therapeutic Inc (TECX). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Tectonic Therapeutic Inc Stock (TECX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
SPRINGER TIMOTHY A
Director
Apr 10 '25
Buy
16.73
45,858
767,204
1,449,652
SPRINGER TIMOTHY A
Director
Apr 09 '25
Buy
14.76
21,071
311,020
1,403,794
SPRINGER TIMOTHY A
Director
Apr 11 '25
Buy
16.31
9,478
154,586
4,334,846
SPRINGER TIMOTHY A
Director
Apr 10 '25
Buy
16.73
8,092
135,379
4,325,368
SPRINGER TIMOTHY A
Director
Apr 09 '25
Buy
14.76
3,718
54,880
4,317,276
SPRINGER TIMOTHY A
Director
Apr 07 '25
Buy
17.10
412,500
7,053,750
1,382,723
SPRINGER TIMOTHY A
Director
Apr 07 '25
Buy
17.10
87,500
1,496,250
4,313,558
MCGUIRE TERRANCE
Director
Apr 07 '25
Sale
17.10
500,000
8,550,000
573,062
SPRINGER TIMOTHY A
Director
Feb 05 '25
Buy
50.00
660,000
33,000,000
970,223
SPRINGER TIMOTHY A
Director
Feb 05 '25
Buy
54.14
129,294
6,999,977
4,226,058
$21.84
price up icon 2.36%
$83.15
price down icon 0.82%
$32.01
price up icon 0.52%
$102.43
price up icon 0.01%
$163.94
price up icon 0.83%
biotechnology ONC
$326.40
price up icon 1.37%
Cap:     |  Volume (24h):